228 related articles for article (PubMed ID: 7514583)
1. The immunologic staging of chronic active hepatitis B patients in Hawaii.
Ching N; Lumeng J; Pon E; Ching CY
Hawaii Med J; 1994 Feb; 53(2):44-5, 49. PubMed ID: 7514583
[TBL] [Abstract][Full Text] [Related]
2. Patterns of natural killer cell function activation in response to interferon in chronic HBsAG positive hepatitis: relationship with the state of viral infection and with the early clinical response.
Actis GC; Maran E; Bonino F; Saracco G; Rosina F; Brunetto MR; Baldi M; Rizzetto M; Verme G; Rocca B
J Biol Regul Homeost Agents; 1987; 1(1):45-50. PubMed ID: 2461050
[TBL] [Abstract][Full Text] [Related]
3. Virus-associated receptors for polymerized human serum albumin in acute and in chronic hepatitis B virus infection.
Pontisso P; Alberti A; Bortolotti F; Realdi G
Gastroenterology; 1983 Feb; 84(2):220-6. PubMed ID: 6336707
[TBL] [Abstract][Full Text] [Related]
4. [Interferon treatment of chronic viral hepatitis].
Pirovino M
Ther Umsch; 1992 May; 49(5):302-9. PubMed ID: 1377840
[TBL] [Abstract][Full Text] [Related]
5. Natural killer activity in patients with acute viral hepatitis.
Chemello L; Mondelli M; Bortolotti F; Schiavon E; Pontisso P; Alberti A; Rondanelli EG; Realdi G
Clin Exp Immunol; 1986 Apr; 64(1):59-64. PubMed ID: 3089650
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of delta-antibody among chronic hepatitis B virus infected patients in the Los Angeles area: its correlation with liver biopsy diagnosis.
Govindarajan S; Kanel GC; Peters RL
Gastroenterology; 1983 Jul; 85(1):160-2. PubMed ID: 6852449
[TBL] [Abstract][Full Text] [Related]
7. In situ characterization by monoclonal antibodies of the mononuclear cell infiltrate in chronic active hepatitis.
Colucci G; Colombo M; Del Ninno E; Paronetto F
Gastroenterology; 1983 Nov; 85(5):1138-45. PubMed ID: 6225691
[TBL] [Abstract][Full Text] [Related]
8. [Clinical and virological evaluation of the detection of pre-S1 and pre-S2 antigens in serum from patients with chronic hepatitis B].
Zoulim F; Capel F; Berthillon P; Trépo C; Petit MA
Gastroenterol Clin Biol; 1995 Dec; 19(12):970-5. PubMed ID: 8729407
[TBL] [Abstract][Full Text] [Related]
9. Approaches to the treatment of hepatitis B virus and delta-related liver disease.
Thomas HC; Lever AM; Scully LJ; Pignatelli M
Semin Liver Dis; 1986 Feb; 6(1):34-41. PubMed ID: 2424091
[No Abstract] [Full Text] [Related]
10. T lymphocyte subpopulations in patients with chronic active hepatitis B virus infection characterized by monoclonal antibodies.
Dworniak D; Tchórzewski H; Pokoca L; Tkacz B; Drobnik S; Baj Z
Arch Immunol Ther Exp (Warsz); 1989; 37(3-4):305-11. PubMed ID: 2639630
[TBL] [Abstract][Full Text] [Related]
11. [Characteristics of immunological phenomena in hepatitis B virus (HBV) infection].
Stachowski J; Michałkiewicz J; Wiernicka J; Maciejewski J; Madaliński K
Postepy Hig Med Dosw; 1987; 41(6):631-62. PubMed ID: 3330222
[No Abstract] [Full Text] [Related]
12. Treatment of chronic B virus hepatitis with specific transfer factor.
Mazzella G; Ronchi M; Villanova N; Mohamed AA; Pizza G; De Vinci C; Viza D; Roda E; Barbara L
J Exp Pathol; 1987; 3(4):421-3. PubMed ID: 3454802
[No Abstract] [Full Text] [Related]
13. [Current clinico-pathogenetic aspects of chronic hepatitis B].
Iakovenko EP
Sov Med; 1991; (1):12-6. PubMed ID: 1862371
[TBL] [Abstract][Full Text] [Related]
14. [The interferon therapy of patients with chronic viral hepatitis: the factors affecting the treatment results].
Kokoreva LN; Zmyzgova AV; Shalygina NB
Ter Arkh; 1996; 68(2):10-4. PubMed ID: 8771646
[TBL] [Abstract][Full Text] [Related]
15. Natural killer cell function during interferon treatment of delta hepatitis.
Actis GC; Maran E; Saracco G; Rosina F; Baldi M; Brunetto M
Prog Clin Biol Res; 1987; 234():305-8. PubMed ID: 3628385
[No Abstract] [Full Text] [Related]
16. [Favorable outcome in chronic active hepatitis caused by B virus in childhood].
Cadrobbi P; Bortolotti F; Crivellaro C; Rugge M; Armigliato M; Realdi G; Bertaggia A
Minerva Pediatr; 1984 Jul; 36(13-14):685-9. PubMed ID: 6503897
[No Abstract] [Full Text] [Related]
17. Circulating ICAM-1 (sCD54) and LFA-3 (sCD58) in chronic hepatitis B--a longitudinal study in patients treated with interferon-alpha.
Knolle PA; Eckardt AJ; Protzer-Knolle U; Schirmacher P; Dienes HP; Meyer zum Büschenfelde KH; Gerken G
Z Gastroenterol; 1997 Jun; 35(6):459-67. PubMed ID: 9231990
[TBL] [Abstract][Full Text] [Related]
18. [Antibody-dependent cell cytotoxicity and the effect of interferon on K-cell functional activity in vitro in chronic viral hepatitis B in children].
Kaganov BS; Zimin IuI; Uchaĭkin VF; Saidov MZ; Sorokin AM
Biull Eksp Biol Med; 1984 Dec; 98(12):700-2. PubMed ID: 6509200
[TBL] [Abstract][Full Text] [Related]
19. Impact of highly active antiretroviral therapy (HAART) on the natural history of hepatitis B virus (HBV) and HIV coinfection: relationship between prolonged efficacy of HAART and HBV surface and early antigen seroconversion.
Miailhes P; Trabaud MA; Pradat P; Lebouché B; Chevallier M; Chevallier P; Zoulim F; Trepo C
Clin Infect Dis; 2007 Sep; 45(5):624-32. PubMed ID: 17682999
[TBL] [Abstract][Full Text] [Related]
20. [Hepatitis B virus (HBV) and the inflammatory/immune response. I. The natural environment of the antigen presentation and immunologic chaos induced by the virus].
Villarrubia VG; Alvarez-Mon M; Chirigos MA; Herrerías JM
Rev Esp Enferm Dig; 1997 Dec; 89(12):919-28. PubMed ID: 9494379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
